Telos Rx vs BreezeMeds: Pricing, formats, and clinician review

Telos Rx vs BreezeMeds: both sell clinician-reviewed GLP-1 options online, but they differ in starting price, product formats, prescribing language, and cancellation or fee transparency. Early verdict: Telos Rx lists semaglutide as low as $99 per month and tirzepatide from $139 if a licensed provider approves you, while BreezeMeds shows semaglutide injection starting at $199 and tirzepatide injection from $299.

See Telos Rx semaglutide from $99

Key differences at a glance for Telos Rx vs BreezeMeds

This comparison focuses on the most distinctive supported differences: starting price, medication formats and compounding status, clinician approval and prescribing language, cancellation and fee transparency, and oral options.

Comparison table

Pricing and what “starting at” means

Telos Rx advertises semaglutide as low as $99 per month and tirzepatide from $139 per month, with explicit language that these apply if a licensed provider approves you and that your price depends on your plan. Telos also states “Pay $0 if not approved” and lists sample price points such as $299 and $399 alongside the per month offers. BreezeMeds displays semaglutide injection from $199 per month and tirzepatide injection from $299, with oral options displayed from $399 and an unclear separate $169 figure. Both providers advise confirming costs and state availability before enrollment.

View BreezeMeds pricing and options

Formats, compounding, and regulatory notes

Telos Rx explicitly identifies semaglutide and tirzepatide as compounded medications and repeats that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds lists injectable and oral semaglutide and tirzepatide but notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. If the compounded status or FDA approval matters to you, the sources advise confirming product type and approval directly with the provider before enrolling.

Prescribing process and clinician review

Both sources say a licensed clinician or US-licensed provider must determine whether treatment is medically appropriate. Telos Rx repeats that medications are prescription-only and prescribed only after review by a US-licensed provider and that treatment is available only when a licensed clinician determines it is medically appropriate. BreezeMeds uses similar clinician-reviewed language and emphasizes that treatment is clinician-determined. The comparison shows both require clinical approval; Telos frames this with explicit language about paying $0 if not approved and that a US-licensed provider decides which molecule is right for you.

Cancellation, shipping, and transparency

Telos Rx states you can cancel anytime with no penalties and warns that pricing, eligibility, pharmacy, state coverage and renewal terms may change. BreezeMeds highlights discreet shipping and ongoing support but captured evidence did not fully display fees, billing commitments or cancellation details, and the $169 offer is not clearly tied to a product. The sources therefore differ in how clearly cancellation and fee terms are presented in the captured evidence.

Check Telos Rx clinician-reviewed options

What to confirm before enrolling

From the captured evidence, confirm all of the following directly with the provider: exact product offered (compounded or branded), starting price that applies to you, whether oral options are available in your state, clinician approval requirements, and cancellation or billing commitments. Both sources include qualifiers that treatment is available only when a licensed clinician determines it is medically appropriate.

Compare Telos Rx plans and clinician review

Conclusion: Telos Rx vs BreezeMeds

Telos Rx vs BreezeMeds shows clear differences in starting price and the formats highlighted. Telos Rx lists semaglutide as low as $99 and tirzepatide from $139 when approved by a US-licensed provider and emphasizes compounded medication status and a cancel anytime, no penalties policy. BreezeMeds lists higher starting prices for injectables and also shows oral options and discreet shipping, though some fee and product ties were not fully visible.

Choose Telos Rx if…

You prioritize lower advertised starting prices for compounded semaglutide or tirzepatide, want the explicit option that you may pay $0 if not approved, and value a stated cancel anytime, no penalties policy. Note that Telos presents compounded medications and states they are not FDA-approved.

Choose BreezeMeds if…

You need injectable and oral GLP-1 options shown on the landing evidence and you want discreet shipping and ongoing support as part of the offer. Confirm which prices and product formats apply to you, since some pricing and fee details were not fully visible in the captured evidence.

For a final check of availability, exact pricing and product status, confirm details with the provider since both sources advise verifying eligibility, medication, total cost, renewal terms and state availability before enrollment. This Telos Rx vs BreezeMeds comparison is limited to the captured source evidence and preserves their stated qualifiers about clinician approval and compounded medication status.